![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 14, 12175-12181, April 4, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§¶,
¶
,
,
, and
**
From the Human filamins are 280-kDa proteins containing an
N-terminal actin-binding domain followed by 24 characteristic repeats.
They also interact with a number of other cellular proteins. All of those identified to date, with the exception of actin, bind to the
C-terminal third of a filamin. In a yeast two-hybrid search of a human
placental library, using as bait repeats 10-18 of filamin B, we
isolated a cDNA coding for a novel 374 amino acid protein containing a proline-rich domain near its N terminus and two LIM domains at its C terminus. We term this protein filamin-binding LIM
protein-1, FBLP-1. Yeast two-hybrid studies with deletion mutants
localized the areas of interaction in FBLP-1 to its N-terminal domain
and in filamin B to repeats 10-13. FBLP-1 mRNA was detected in a
variety of tissues and cells including platelets and endothelial cells.
We also have identified two FBLP-1 variants. Both contain three
C-terminal LIM domains, but one lacks the N-terminal proline-rich domain. Transfection of FBLP-1 into 293A cells promoted stress fiber
formation, and both FBLP-1 and filamin B localized to stress fibers in
the transfected cells. The association between filamin B and FBLP-1 may
play a hitherto unknown role in cytoskeletal function, cell adhesion,
and cell motility.
Department of Medicine, Cardeza Foundation
for Hematologic Research, Jefferson Medical College, Philadelphia,
Pennsylvania 19041, the § Department of Clinical and
Laboratory Medicine, Yamanashi Medical University, Yamanashi 409-3898, Japan, and the
Department of Clinical Pharmaceutical Science,
Graduate School of Medicine, Hiroshima University, Hiroshima 734-8551, Japan
This article has been cited by other articles:
![]() |
M. M.R. Petit, H. Lindskog, E. Larsson, P. Wasteson, E. Athley, S. Breuer, M. Angstenberger, D. Hertfelder, E. Mattsson, A. Nordheim, et al. Smooth Muscle Expression of Lipoma Preferred Partner Is Mediated by an Alternative Intronic Promoter That Is Regulated by Serum Response Factor/Myocardin Circ. Res., July 3, 2008; 103(1): 61 - 69. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lu, G. Lian, R. Lenkinski, A. De Grand, R. R. Vaid, T. Bryce, M. Stasenko, A. Boskey, C. Walsh, and V. Sheen Filamin B mutations cause chondrocyte defects in skeletal development Hum. Mol. Genet., July 15, 2007; 16(14): 1661 - 1675. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S Bicknell, C. Farrington-Rock, Y. Shafeghati, P. Rump, Y. Alanay, Y. Alembik, N. Al-Madani, H. Firth, M. H. Karimi-Nejad, C. A. Kim, et al. A molecular and clinical study of Larsen syndrome caused by mutations in FLNB J. Med. Genet., February 1, 2007; 44(2): 89 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, Y. Tu, V. Gkretsi, and C. Wu Migfilin Interacts with Vasodilator-stimulated Phosphoprotein (VASP) and Regulates VASP Localization to Cell-Matrix Adhesions and Migration J. Biol. Chem., May 5, 2006; 281(18): 12397 - 12407. [Abstract] [Full Text] [PDF] |
||||
![]() |
L S Bicknell, T Morgan, L Bonafe, M W Wessels, M G Bialer, P J Willems, D H Cohn, D Krakow, and S P Robertson Mutations in FLNB cause boomerang dysplasia J. Med. Genet., July 1, 2005; 42(7): e43 - e43. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wu Migfilin and its binding partners: from cell biology to human diseases J. Cell Sci., February 15, 2005; 118(4): 659 - 664. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Gkretsi, Y. Zhang, Y. Tu, K. Chen, D. B. Stolz, Y. Yang, S. C. Watkins, and C. Wu Physical and functional association of migfilin with cell-cell adhesions J. Cell Sci., February 15, 2005; 118(4): 697 - 710. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |